Pharmacological treatment of insomnia for individuals with brain injury.
Flanagan
Steven R
SR
Departments of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. steve.flanagan@mssm.edu
Greenwald
Brian
B
Wieber
Stasia
S
D000928:Antidepressive Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008550:Melatonin / Q000819:agonists; D011725:Pyridines / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology*; D014196:Trazodone / Q000627:therapeutic use; D000077334:Zolpidem
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem; D008550:Melatonin; D014196:Trazodone